Epidemiology of diabetic kidney disease in adult patients with type 1 diabetes in Italy: The AMD-Annals initiative

Diabetes/Metabolism Research and Reviews

Volumn 33, Issue 4, 2017, Pages

  Pacilli, Antonio ^a   Viazzi, Francesca ^b   Fioretto, Paola ^c   Giorda, Carlo ^d   Ceriello, Antonio ^e,f   Genovese, Stefano ^f   Russo, Giuseppina ^g   Guida, Pietro ^h   Pontremoli, Roberto ^b   De Cosmo, Salvatore ^a  

^a CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c UNIVERSITY OF PADOVA   (Italy)

^d Diabete and Metabolism Unit   (Italy)

^e INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^f IRCCS MULTIMEDICA   (Italy)

^g UNIVERSITY OF MESSINA   (Italy)

^h AMD Associazione Medici Diabetologi   (Italy)

Author keywords

albuminuria; chronic kidney disease; epidemiology; glomerular filtration rate; type 1 diabetes

Indexed keywords

ALBUMIN; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; TRIACYLGLYCEROL; URIC ACID;

ADULT; ALBUMINURIA; ARTICLE; CARDIOVASCULAR RISK; CONFIDENCE INTERVAL; DIABETIC NEPHROPATHY; DIABETIC PATIENT; DIABETIC RETINOPATHY; DISEASE DURATION; ELECTRONIC MEDICAL RECORD; EPIDEMIOLOGICAL DATA; ESTIMATED GLOMERULAR FILTRATION RATE; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; SMOKE; SYSTOLIC BLOOD PRESSURE; URIC ACID BLOOD LEVEL; BLOOD PRESSURE; ITALY; PATHOPHYSIOLOGY; PHYSIOLOGY; PREVALENCE; RISK FACTOR; SEX FACTOR;

ADULT; ALBUMINURIA; BLOOD PRESSURE; DIABETES MELLITUS, TYPE 1; DIABETIC NEPHROPATHIES; FEMALE; HUMANS; ITALY; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS; SEX FACTORS;

EID: 85010280614     PISSN: 15207552     EISSN: 15207560     Source Type: Journal    
DOI: 10.1002/dmrr.2873     Document Type: Article

References (38)

1. International Diabetes Federation. Diabetes Atlas. 7th ed. 2015.http://www.idf.org/idf-diabetes-atlas-seventh-edition
2. Nathan DM, Bayless M, Cleary P, et al. Diabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30 years: advances and contributions. Diabetes. 2013;62:3976–3986.
3. Jørgensen ME, Almdal TP, Carstensen B. Time trends in mortality rates in type 1 diabetes from 2002 to 2011. Diabetologia. 2013;56:2401–2404.
4. Lind M, Svensson AM, Kosiborod M, et al. Glycemic control and excess mortality in type 1 diabetes. N Engl J Med. 2014;371:1972–1982.
5. Groop PH, Thomas MC, Moran JL, et al. FinnDiane study group: the presence and severity of chronic kidney disease predicts all-cause mortality in type 1 diabetes. Diabetes. 2009;58:1651–1658.
6. Parving HH, Mauer M, Ritz E. Diabetic nephropaty. In: Brenner BM, ed. The Kidney. 7th ed. Ed. Philadelphia, PA: Elsevier; 2004.
7. Rossing P. Diabetic nephropathy: worldwide epidemic and effects of current treatment on natural history. Curr Diab Rep. 2006;6:479–483.
8. United States Renal Data System. Annual report 2015. http://www.usrds.org/2015/view/Default.aspx.
9. Krolewsky AS. Progressive renal decline: the new paradigm of diabetic nephropathy in type 1 diabetes. Diabetes Care. 2015;38:954–962.
10. Rossing P. The changing epidemiology of diabetic microangiopathy in type 1 diabetes. Diabetologia. 2005;48:1439–1444.
11. Pezzolesi MG, Poznik GD, Mychaleckyj JC, et al. Genome-wide association scan for diabetic nephropathy susceptibility genes in type 1 diabetes. Diabetes. 2009;58:1403–1410.
12. Hovind P, Tarnow L, Rossing P, et al. Predictorsforthedevelopmentofmicroalbuminuriaandmacroalbuminuriainpatientswithtype1diabetes:inceptioncohortstudy. BMJ. 2004;328(1105):
13. Feodoroff M, Harjutsalo V, Forsblom C, et al. Smokingandprogressionofdiabeticnephropathyinpatientswithtype1diabetes. Acta Diabetol. 2015 Dec 14; [Epub ahead of print]
14. Nicolucci A, Rossi MC, Arcangeli A, et al. AMD-Annals study group. Four year impact of a continuous quality improvement effort implemented by a network of diabetes outpatient clinics: the AMD-Annals initiative. Diabet Med. 2010;27:1041–1048.
15. De Cosmo S, Viazzi F, Pacilli A, et al. AMD-Annals study group. Serum uric acid and risk of CKD in type 2 diabetes. Clin J Am Soc Nephrol. 2015;10:1921–1929.
16. Levey AS, Stevens LA, Schmid CH, et al. CKD-EPI (chronic kidney disease epidemiology collaboration). A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150:604–612.
17. Deckert T, Feldt-Rasmussen B, Borch-Johnsen K, Jensen T, Kofoed-Enevoldsen A. Albuminuria reflects widespread vascular damage. The steno hypothesis. Diabetologia. 1989;32:219–226.
18. Soedamah-Muthu SS, Chaturvedi N, Witte DR, et al. Study group. Relationship between risk factors and mortality in type 1 diabetic patients in Europe: the EURODIAB prospective complications study (PCS). Diabetes Care. 2008;31:1360–1366.
19. The DCCT/EDIC research group. Effect of intensive diabetes treatment on albuminuria in type 1 diabetes: long-term follow-up of the diabetes control and complications trial and epidemiology of diabetes interventions and complications study. The Lancet Diabetes & Endocrinology. 2014;2:793–800.
20. de Boer IH, Rue TC, Hall YN, Heagerty PJ, Weiss NS, Himmelfarb J. Temporal trends in the prevalence of diabetic kidney disease in the United States. JAMA. 2011;305:2532–2539.
21. Forssas E, Arffman M, Manderbacka K, Keskimäki I, Ruuth I, Sund R. Multiple complications among people with diabetes from Finland: an 18-year follow-up in 1994–2011. BMJ Open Diab Res Care. 2016;4:1 e000254
22. Svensson MK, Tyrberg M, Nyström L, et al. The risk for diabetic nephropathy is low in young adults in a 17-year follow-up from the diabetes incidence study in Sweden (DISS). Older age and higher BMI at diabetes onset can be important risk factors. Diabetes Metab Res Rev. 2015;31:138–146.
23. Esmatjes E, De Alvaro F. “Estudio Diamante” investigators. Incidenceofdiabeticnephropathyintype1diabeticpatientsinSpain:“EstudioDiamante”. Diabetes Res Clin Pract. 2002;57:35–43.
24. Chaturvedi N, Bandinelli S, Mangili R, Penno G, Rottiers RE, Fuller JH. Microalbuminuria in type 1 diabetes: rates, risk factors and glycemic threshold. Kidney Int. 2001;60:219–227.
25. Molitch ME, Steffes M, Sun W, et al. Epidemiology of diabetes interventions and complications study group. Development and progression of renal insufficiency with and without albuminuria in adults with type 1 diabetes in the diabetes control and complications trial and the epidemiology of diabetes interventions and complications study. Diabetes Care. 2010;33:1536–1543.
26. Caramori ML, Fioretto P, Mauer M. Low glomerular filtration rate in normoalbuminuric type 1 diabetic patients: an indicator of more advanced glomerular lesions. Diabetes. 2003;52:1036–1040.
27. Caramori ML, Parks A, Mauer M. Renal lesions predict progression of diabetic nephropathy in type 1 diabetes. J Am Soc Nephrol. 2013;24:1175–1181.
28. Thorn LM, Gordin D, Harjutsalo V, et al. FinnDiane study group. The presence and consequence of Nonalbuminuric chronic kidney disease in patients with type 1 diabetes. Diabetes Care. 2015;38:2128–2133.
29. de Boer I, Rue T, Cleary P, et al. Diabetes control and complications trial/epidemiology of diabetes interventions and complications study research group, white NH, Danis RP, Davis MD, Hainsworth D, Hubbard LD, Nathan DM. Long-term renal outcomes of patients with type 1 diabetes mellitus and microalbuminuria: an analysis of the diabetes control and complications trial/epidemiology of diabetes interventions and complications cohort. Arch Intern Med. 2011;171:412–420.
30. Smith HW. Comparative physiology of the kidney. In: Smith HW, ed. The Kidney: Structure and Function in Health and Disease. New York, NY: Oxford University Press; 1951:520–574.
31. Delanaye P, Schaeffner E, Ebert N, et al. Normal reference values for glomerular filtration rate: what do we really know? Nephrol Dial Transplant. 2012;27:2664–2672.
32. Botev R et al. The clinician and estimation of glomerular filtration rate by creatinine-based formulas: current limitations and quo Vadis. Clin J Am Soc Nephrol. 2011;6:937–950.
33. de Boer IH, Sun W, Cleary PA, et al. DCCT/EDIC research group. Intensive diabetes therapy and glomerular filtration rate in type 1 Diabetes. N Engl J Med. 2011;365:2366–2376.
34. De Cosmo S, Menzaghi C, Prudente S, Trischitta V. Roleofinsulinresistanceinkidneydysfunction:insightsintothemechanismandepidemiologicalevidence. Nephrol Dial Transplant. 2013;28:29–36.
35. Haynes R, Lewis D, Emberson J, et al. Effects of lowering LDL cholesterol on progression of kidney disease. J Am Soc Nephrol. 2014;25:1825–1833.
36. Hovind P, Rossing P, Tarnow L, Johnson RJ, Parving HH. Serum uric acid as a predictor for development of diabetic nephropathy in type 1 diabetes: an inception cohort study. Diabetes. 2009;58:1668–1671.
37. Wu HY, Peng YS, Chiang CK, et al. Diagnostic performance of random urine samples using albumin concentration vs ratio of albumin to creatinine for microalbuminuria screening in patients with diabetes mellitus: a systematic review and meta-analysis. JAMA Intern Med. 2014;174:1108–1115.
38. Pugliese G, Solini A, Fondelli C, et al. Renal insufficiency and cardiovascular events (RIACE) study group. Reproducibility of albuminuria in type 2 diabetic subjects. Findings from the renal insufficiency and cardiovascular events (RIACE) study. Nephrol Dial Transplant. 2011;26:3950–3954.